Table 1.
Distribution of isolates tested (n) and percentage of isolates with an antimicrobial-resistant phenotype (% Res) to antimicrobial agents among Staphylococcus aureus isolated from nasal swabs.
| Antimicrobial Category | Antimicrobial Agents |
Staphylococcus aureus (Total Isolates = 493) |
|
|---|---|---|---|
| n | % Res | ||
| Penicillins | PEN | 491 | 73.9 |
| OXA | 489 | 18.2 | |
| Fluoroquinolones | LVX | 364 | 21.2 |
| Aminoglycosides | GEN | 363 | 5.8 |
| Macrolides | ERY | 363 | 32 |
| Lincosamides | CLI | 361 | 29.9 |
| Tetracyclines | TET | 363 | 4.4 |
| Folate pathway inhibitors | SXT | 363 | 2.8 |
| Glycopeptides | VAN | 364 | 0.3 |
| TEC | 362 | 2.8 | |
| Oxazolidinones | LZD | 364 | 0.5 |
| Lipopeptides | DAP | 363 | 0.3 |
Abbreviations: Res, isolates with an antimicrobial-resistant phenotype; CLI, clindamycin; DAP, daptomycin.; ERY, erythromycin; GEN, gentamicin; LVX, levofloxacin; LZD, linezolid; OXA, oxacillin; PEN, benzylpenicillin; SXT, trimethoprim-sulfamethoxazole; TEC, teicoplanin; TET, tetracycline; VAN, vancomycin.